Dr Craske sent a copy of his paper about AIDS to Dr Rizza and to Dr Ludlam Read more about Dr Craske sent a copy of his paper about AIDS to Dr Rizza and to Dr Ludlam
Dr Rizza wrote that AIDS had caused a stir in the haemophilia world and one very senior physician had withdrawn his factor VIII concentrates from the accident room and insisted on vetting the patients himself before any dose was given. Dr Rizza felt that AIDS "should be looked at urgently if only to clear the air and dispel some of the apprehension that has been stirred up". Read more about Dr Rizza wrote that AIDS had caused a stir in the haemophilia world and one very senior physician had withdrawn his factor VIII concentrates from the accident room and insisted on vetting the patients himself before any dose was given. Dr Rizza felt that AIDS "should be looked at urgently if only to clear the air and dispel some of the apprehension that has been stirred up".
The UKHCDs Hepatitis Working Party agreed that, as AIDS had similarities in its epidemiology to Hepatitis B, enquiries would be made by members of the Working Party to ascertain the likelihood of transmission by blood or blood products and a further meeting would be held when more information was available. Read more about The UKHCDs Hepatitis Working Party agreed that, as AIDS had similarities in its epidemiology to Hepatitis B, enquiries would be made by members of the Working Party to ascertain the likelihood of transmission by blood or blood products and a further meeting would be held when more information was available.
Dr Craske circulated a prospective study protocol. Any haemophilia centre directors could use the protocol when evaluating any new concentrate products; directors would be invited to report the results in a standardised way to the UKHCDs Hepatitis Working Party and to retain serial samples of each patient's serum so a collection would be available to evaluate any new marker tests for NANBH. Read more about Dr Craske circulated a prospective study protocol. Any haemophilia centre directors could use the protocol when evaluating any new concentrate products; directors would be invited to report the results in a standardised way to the UKHCDs Hepatitis Working Party and to retain serial samples of each patient's serum so a collection would be available to evaluate any new marker tests for NANBH.
The average amount of factor IX concentrate used per haemophilia B patient increased to 26,769 units at thr UK Haemophilia Centres. Read more about The average amount of factor IX concentrate used per haemophilia B patient increased to 26,769 units at thr UK Haemophilia Centres.
A summary of all the Annual Returns for UK Haemophilia Centres for the year 1981 were produced. Read more about A summary of all the Annual Returns for UK Haemophilia Centres for the year 1981 were produced.
Dr Craske said he would find out more about AIDS following reports in the US and the possible relationship with blood products Read more about Dr Craske said he would find out more about AIDS following reports in the US and the possible relationship with blood products
Professor Bloom wondered what the value of giving the hepatitis B vaccine was when non-A, non-B seemed to be a bigger problem Read more about Professor Bloom wondered what the value of giving the hepatitis B vaccine was when non-A, non-B seemed to be a bigger problem
Estimated requirements for factor VIII was discussed at the meeting of haemophilia directors in autumn 1982 Read more about Estimated requirements for factor VIII was discussed at the meeting of haemophilia directors in autumn 1982
The 1981 annual returns were discussed at the meeting of haemophilia directors in autumn 1982. Read more about The 1981 annual returns were discussed at the meeting of haemophilia directors in autumn 1982.